Literature DB >> 21940994

γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.

Nadine Kämper1, Sebastian Franken, Sebastian Temme, Susanne Koch, Thomas Bieber, Norbert Koch.   

Abstract

Antigen presentation by human lymphocyte antigen (HLA) class II peptide receptors alerts the immune system to infections. In antigen-presenting cells (APCs), HLA class II, HLA-DM, and associated invariant chain-encoding genes are exclusively regulated by the interferon γ (IFNγ)-inducible class II transactivator (CIITA). Control of CIITA expression could therefore govern expression of class II peptide receptors in the diverse group of APCs. We discovered that elevation of the HLA class III region encoded B-associated transcript 3 (BAT3) increases and depletion of BAT3 decreases expression of HLA class II, HLA-DM, and invariant chain. IFNγ strongly elevates BAT3 transcription in various tumor cell lines and in primary macrophages. BAT3 chaperones the simultaneously IFNγ-induced CIITA. Following IFNγ-treatment, both CIITA and BAT3 translocate from the cytosol to the nucleus. The nuclear import of CIITA mediated by IFNγ controls activation of HLA class II genes. BAT3 is a novel key regulator of components of the HLA class II processing pathway. We present a mechanism explaining how parallel IFNγ-mediated regulation of CIITA and of its chaperone BAT3 controls the level of components of the HLA class II processing pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940994     DOI: 10.1096/fj.11-189670

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  15 in total

1.  Bag6 complex contains a minimal tail-anchor-targeting module and a mock BAG domain.

Authors:  Jee-Young Mock; Justin William Chartron; Ma'ayan Zaslaver; Yue Xu; Yihong Ye; William Melvon Clemons
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

Review 2.  Dendritic cell-derived exosomes for cancer therapy.

Authors:  Jonathan M Pitt; Fabrice André; Sebastian Amigorena; Jean-Charles Soria; Alexander Eggermont; Guido Kroemer; Laurence Zitvogel
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

Review 3.  Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.

Authors:  Luis C Antón; Jonathan W Yewdell
Journal:  J Leukoc Biol       Date:  2014-02-14       Impact factor: 4.962

Review 4.  BAG-6, a jack of all trades in health and disease.

Authors:  Janina Binici; Joachim Koch
Journal:  Cell Mol Life Sci       Date:  2013-12-04       Impact factor: 9.261

5.  A novel BAT3 sequence generated by alternative RNA splicing of exon 11B displays cell type-specific expression and impacts on subcellular localization.

Authors:  Nadine Kämper; Jörg Kessler; Sebastian Temme; Claudia Wegscheid; Johannes Winkler; Norbert Koch
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

Review 6.  Bag6/Bat3/Scythe: a novel chaperone activity with diverse regulatory functions in protein biogenesis and degradation.

Authors:  Jin-Gu Lee; Yihong Ye
Journal:  Bioessays       Date:  2013-02-18       Impact factor: 4.653

7.  Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations.

Authors:  Godfrey Essien Etokebe; Shanbeh Zienolddiny; Zeljko Kupanovac; Morten Enersen; Sanja Balen; Veljko Flego; Ljiljana Bulat-Kardum; Anđelka Radojčić-Badovinac; Vidar Skaug; Per Bakke; Aage Haugen; Zlatko Dembic
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  BAT2 and BAT3 polymorphisms as novel genetic risk factors for rejection after HLA-related SCT.

Authors:  Silvia Gregori; Rosa Bacchetta; Ignazio Stefano Piras; Andrea Angius; Marco Andreani; Manuela Testi; Guido Lucarelli; Matteo Floris; Sarah Marktel; Fabio Ciceri; Giorgio La Nasa; Katharina Fleischhauer; Maria Grazia Roncarolo; Alessandro Bulfone
Journal:  Bone Marrow Transplant       Date:  2014-08-11       Impact factor: 5.483

Review 9.  HLA-dependent tumour development: a role for tumour associate macrophages?

Authors:  Maddalena Marchesi; Emilia Andersson; Lisa Villabona; Barbara Seliger; Andreas Lundqvist; Rolf Kiessling; Giuseppe V Masucci
Journal:  J Transl Med       Date:  2013-10-06       Impact factor: 5.531

10.  Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

Authors:  Benjamin Besse; Mélinda Charrier; Valérie Lapierre; Eric Dansin; Olivier Lantz; David Planchard; Thierry Le Chevalier; Alain Livartoski; Fabrice Barlesi; Agnès Laplanche; Stéphanie Ploix; Nadège Vimond; Isabelle Peguillet; Clotilde Théry; Ludovic Lacroix; Inka Zoernig; Kavita Dhodapkar; Madhav Dhodapkar; Sophie Viaud; Jean-Charles Soria; Katrin S Reiners; Elke Pogge von Strandmann; Frédéric Vély; Sylvie Rusakiewicz; Alexander Eggermont; Jonathan M Pitt; Laurence Zitvogel; Nathalie Chaput
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.